This article has been updated to include net proceeds from the offering and additional historical stock data.
NEW YORK (GenomeWeb News) – Sequenom has gained net proceeds of roughly $80.1 million from Thursday's public offering of 5.5 million shares at $15.50 per share, a slight discount to Wednesday’s closing price of $15.94.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.